Heterogeneous tissue microenvironment (TME)

The heterogeneous tissue microenvironment (TME) refers to the complex and dynamic cellular and non-cellular environment surrounding a specific cell type, most notably in the context of tumors [1]. It consists of the extracellular matrix (ECM), blood vessels, immune cells, fibroblasts, and signaling molecules like cytokines and growth factors [2]. The TME plays a critical role in disease progression, particularly in cancer, where it can promote tumor growth, facilitate metastasis, and provide a sanctuary from therapeutic interventions [3]. Because the TME is highly heterogeneous and varies between patients and even within different regions of the same tumor, it presents a significant challenge for drug delivery and efficacy [4]. Therapeutic strategies often aim to 'reprogram' the TME to enhance immune response or normalize the vasculature to improve drug penetration [5]. This environment is not a single molecular target but rather a systemic landscape that influences the pharmacodynamics of many drugs [2]. Key components like cancer-associated fibroblasts and the dense collagen matrix can act as physical barriers to therapy [4]. Understanding the spatial and temporal heterogeneity of the TME is essential for developing personalized medicine approaches [3].

Other names

Tumor microenvironmentStromaExtracellular nicheCellular microenvironment

Modulation of the extracellular matrix, inhibition of pro-angiogenic signaling, recruitment or activation of immune cells, and alteration of metabolic conditions such as hypoxia or acidity [2, 5].